ACHV
Achieve Life Sciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$584.13M
P/E Ratio
—
EPS
$-1.07
Beta
2.26
52W High
$6.16
52W Low
$2.00
50-Day MA
$4.58
200-Day MA
$4.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
35.34
PEG Ratio
17.68
About Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and markets cytisinicline for smoking and nicotine addiction cessation in the United States and internationally. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-52.23M |
| Operating Margin | 0.00% |
| Return on Equity | -496.20% |
| Return on Assets | -108.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.20 |
| Price-to-Book | 53.17 |
| Price-to-Sales (TTM) | 5.09 |
| EV/Revenue | 0.625 |
| EV/EBITDA | -2.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $102.66M |
| Float | $87.24M |
| % Insiders | 0.93% |
| % Institutions | 60.97% |
Historical Volatility
HV 10-Day
67.91%
HV 20-Day
85.60%
HV 30-Day
80.92%
HV 60-Day
123.27%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($13.11 target)
2
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026